Status:
WITHDRAWN
Study of MSC-Exo on the Therapy for Intensively Ill Children
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Sepsis
Critical Illness
Eligibility:
All Genders
29-18 years
Brief Summary
At present, a number of projects related to MSCs have been approved for graft-versus-host disease, myocardial infarction, Crohn's disease and other diseases, indicating a strong therapeutic potential ...
Detailed Description
Mesenchymal stem cells (MSCs) are pluripotent stem cells with high self-renewal ability and multidirectional differentiation potential. studies revealed that local or systemic administration of mesenc...
Eligibility Criteria
Inclusion
- children hospitalized in PICU of Children's Hospital of Fudan University
Exclusion
- discharge within 48 hours
- patients without informed consent
- incomplete clinical and demographic data
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04850469
Start Date
September 1 2022
End Date
December 31 2024
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China